{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T14:55:05Z","timestamp":1774104905231,"version":"3.50.1"},"reference-count":73,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Hematology"],"published-print":{"date-parts":[[2005,1]]},"DOI":"10.1053\/j.seminhematol.2004.10.002","type":"journal-article","created":{"date-parts":[[2005,5,12]],"date-time":"2005-05-12T14:42:06Z","timestamp":1115908926000},"page":"15-28","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Phenotypic and genotypic diagnosis of von Willebrand disease: A 2004 update"],"prefix":"10.1053","volume":"42","author":[{"given":"Reinhard","family":"Schneppenheim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrich","family":"Budde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.seminhematol.2004.10.002_bib1","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0021-9258(17)42483-5","article-title":"von Willebrand factor. A reduced and alkylated 52\/48-kDa fragment beginning at amino acid residue 449 contains the domain interacting with platelet glycoprotein Ib","volume":"261","author":"Fujimura","year":"1986","journal-title":"J Biol Chem"},{"key":"10.1053\/j.seminhematol.2004.10.002_bib2","doi-asserted-by":"crossref","first-page":"8057","DOI":"10.1073\/pnas.82.23.8057","article-title":"The effect of Arg-Gly-Asp-containing peptides on fibrinogen and von Willebrand factor binding to platelets","volume":"82","author":"Plow","year":"1985","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.seminhematol.2004.10.002_bib3","doi-asserted-by":"crossref","first-page":"8443","DOI":"10.1016\/S0021-9258(18)47430-3","article-title":"A major factor VIII binding domain resides within the amino-terminal 272 amino acid residues of von Willebrand factor","volume":"262","author":"Foster","year":"1987","journal-title":"J Biol Chem"},{"key":"10.1053\/j.seminhematol.2004.10.002_bib4","doi-asserted-by":"crossref","first-page":"13835","DOI":"10.1016\/S0021-9258(19)76501-6","article-title":"Isolation and characterization of two domains of human von Willebrand factor that interact with fibrillar collagen types I and III","volume":"262","author":"Pareti","year":"1987","journal-title":"J Biol Chem"},{"key":"10.1053\/j.seminhematol.2004.10.002_bib5","doi-asserted-by":"crossref","first-page":"17361","DOI":"10.1016\/S0021-9258(18)71501-9","article-title":"Isolation of the von Willebrand factor domain interacting with platelet glycoprotein Ib, heparin, and collagen and characterization of its three distinct functional sites","volume":"264","author":"Mohri","year":"1989","journal-title":"J Biol Chem"},{"key":"10.1053\/j.seminhematol.2004.10.002_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-0037-1619601","article-title":"Platelet and von Willebrand factor interactions at the vessel wall","volume":"24","author":"Ruggeri","year":"2004","journal-title":"Hamostaseologie"},{"key":"10.1053\/j.seminhematol.2004.10.002_bib7","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1172\/JCI108788","article-title":"Stabilization of factor VIII in plasma by the von Willebrand factor. Studies on posttransfusion and dissociated factor VIII and in patients with von Willebrand\u2019s disease","volume":"60","author":"Weiss","year":"1977","journal-title":"J Clin Invest"},{"key":"10.1053\/j.seminhematol.2004.10.002_bib8","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0049-3848(96)00161-2","article-title":"Effect of multimerization of human and recombinant von Willebrand factor on platelet aggregation, binding to collagen and binding of coagulation factor VIII","volume":"84","author":"Fischer","year":"1996","journal-title":"Thromb Res"},{"key":"10.1053\/j.seminhematol.2004.10.002_bib9","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.1073\/pnas.89.8.3531","article-title":"Vicinal cysteines in the prosequence play a role in von Willebrand factor multimer assembly","volume":"89","author":"Mayadas","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.seminhematol.2004.10.002_bib10","doi-asserted-by":"crossref","first-page":"8099","DOI":"10.1021\/bi00399a013","article-title":"Identification of disulfide-bridged substructures within human von Willebrand factor","volume":"26","author":"Marti","year":"1987","journal-title":"Biochemistry"},{"key":"10.1053\/j.seminhematol.2004.10.002_bib11","doi-asserted-by":"crossref","first-page":"3581","DOI":"10.1073\/pnas.93.8.3581","article-title":"Defective dimerization of von Willebrand factor subunits due to a Cys\u2192Arg mutation in type IID von Willebrand disease","volume":"93","author":"Schneppenheim","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.seminhematol.2004.10.002_bib12","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1182\/blood.V97.7.2059","article-title":"Expression and characterization of von Willebrand factor dimerization defects in different types of von Willebrand disease","volume":"97","author":"Schneppenheim","year":"2001","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2004.10.002_bib13","first-page":"566a","article-title":"Von Willebrand disease type 2A with aberrant structure of individual oligomers is caused by mutations clustering in the von Willebrand factor D3 domain","volume":"96","author":"Schneppenheim","year":"2000","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2004.10.002_bib14","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1182\/blood.V84.4.1024.1024","article-title":"Characterization of von Willebrand factor gene defects in two unrelated patients with type IIC von Willebrand disease","volume":"84","author":"Gaucher","year":"1994","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2004.10.002_bib15","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/BF00209487","article-title":"Identification of a candidate missense mutation in a family with von Willebrand disease type IIC","volume":"95","author":"Schneppenheim","year":"1995","journal-title":"Hum Genet"},{"key":"10.1053\/j.seminhematol.2004.10.002_bib16","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1055\/s-0037-1615051","article-title":"Ins405AsnPro mutation in the von Willebrand factor propeptide in recessive type 2A (IIC) von Willebrand\u2019s disease","volume":"79","author":"Holmberg","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1053\/j.seminhematol.2004.10.002_bib17","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1182\/blood.V96.2.560.014k01_560_568","article-title":"A novel von Willebrand disease-causing mutation (Arg273Trp) in the von Willebrand factor propeptide that results in defective multimerization and secretion","volume":"96","author":"Allen","year":"2000","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2004.10.002_bib18","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1182\/blood-2002-03-0789","article-title":"The role of the D1 domain of the von Willebrand factor propeptide in multimerization of VWF","volume":"100","author":"Rosenberg","year":"2002","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2004.10.002_bib19","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1056\/NEJM198005083021902","article-title":"Heightened interaction between platelets and factor VIII\/von Willebrand factor in a new subtype of von Willebrand\u2019s disease","volume":"302","author":"Ruggeri","year":"1980","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminhematol.2004.10.002_bib20","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/00001721-199102000-00005","article-title":"Pregnancy-induced worsening of thrombocytopenia in a patient with type IIB von Willebrand\u2019s disease","volume":"2","author":"Casonato","year":"1991","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1053\/j.seminhematol.2004.10.002_bib21","first-page":"117","article-title":"1-Desamino-8-D-arginine vasopressin (DDAVP) infusion in type IIB von Willebrand\u2019s disease","volume":"64","author":"Casonato","year":"1900","journal-title":"Thromb Haemost"},{"key":"10.1053\/j.seminhematol.2004.10.002_bib22","first-page":"58","article-title":"Type IIB von Willebrand\u2019s disease","volume":"82","author":"Donner","year":"1992","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2004.10.002_bib23","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1182\/blood.V74.5.1591.1591","article-title":"New variant of von Willebrand disease with defective binding to factor VIII","volume":"74","author":"Nishino","year":"1989","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2004.10.002_bib24","first-page":"7","article-title":"Heredit\u00e4r pseudohemofili","volume":"672","author":"von Willebrand","year":"1926","journal-title":"Finska Lakaresallskapets Handlingar"},{"key":"10.1053\/j.seminhematol.2004.10.002_bib25","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1182\/blood.V77.9.1937.1937","article-title":"The \u201cNormandy\u201d variant of von Willebrand disease","volume":"77","author":"Gaucher","year":"1991","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2004.10.002_bib26","doi-asserted-by":"crossref","first-page":"13499","DOI":"10.1016\/S0021-9258(18)92725-0","article-title":"Molecular characterization of a unique von Willebrand disease variant. A novel mutation affecting von Willebrand factor\/factor VIII interaction","volume":"266","author":"Cacheris","year":"1991","journal-title":"J Biol Chem"},{"key":"10.1053\/j.seminhematol.2004.10.002_bib27","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1055\/s-0038-1650628","article-title":"Results of a screening for von Willebrand disease type 2N in patients with suspected haemophilia A or von Willebrand disease type 1","volume":"76","author":"Schneppenheim","year":"1996","journal-title":"Thromb Haemost"},{"key":"10.1053\/j.seminhematol.2004.10.002_bib28","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1160\/TH04-02-0084","article-title":"Recombinant expression of mutations causing von Willebrand disease type Normandy","volume":"92","author":"Schneppenheim","year":"2004","journal-title":"Thromb Haemost"},{"key":"10.1053\/j.seminhematol.2004.10.002_bib29","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1055\/s-0038-1642471","article-title":"A revised classification of von Willebrand disease","volume":"71","author":"Sadler","year":"1994","journal-title":"Thromb Haemost"},{"key":"10.1053\/j.seminhematol.2004.10.002_bib30","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1055\/s-0037-1616142","article-title":"Ser968Thr mutation within the A3 domain of von Willebrand factor (VWF) in two related patients leads to a defective binding of VWF to collagen","volume":"86","author":"Ribba","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1053\/j.seminhematol.2004.10.002_bib31","first-page":"165","article-title":"Isolated molecular defects of von Willebrand factor binding to collagen do not correlate with bleeding symptoms","volume":"98","author":"Schneppenheim","year":"2001","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2004.10.002_bib32","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1182\/blood.V71.1.65.65","article-title":"von Willebrand disease \u201cVicenza\u201d with larger-than-normal (supranormal) von Willebrand factor multimers","volume":"71","author":"Mannucci","year":"1988","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2004.10.002_bib33","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1182\/blood.V99.1.180","article-title":"Reduced von Willebrand factor survival in type Vicenza von Willebrand disease","volume":"99","author":"Casonato","year":"2002","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2004.10.002_bib34","doi-asserted-by":"crossref","first-page":"12102","DOI":"10.1074\/jbc.M310436200","article-title":"An experimental model to study the in vivo survival of von Willebrand factor. Basic aspects and application to the R1205H mutation","volume":"279","author":"Lenting","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1053\/j.seminhematol.2004.10.002_bib35","series-title":"Thrombosis and Haemostasis","first-page":"419","article-title":"Classification of von Willebrand disease","author":"Rugggeri","year":"1987"},{"key":"10.1053\/j.seminhematol.2004.10.002_bib36","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1053\/beha.2001.0136","article-title":"Congenital von Willebrand disease type I","volume":"14","author":"Rodeghiero","year":"2001","journal-title":"Baillieres Clin Haematol"},{"key":"10.1053\/j.seminhematol.2004.10.002_bib37","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1182\/blood-2002-09-2892","article-title":"Von Willebrand disease type 1","volume":"101","author":"Sadler","year":"2003","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2004.10.002_bib38","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0049-3848(90)90129-Z","article-title":"Platelet von Willebrand factor assay\u2014Results using 2 methods for platelet lysis","volume":"59","author":"Rodeghiero","year":"1990","journal-title":"Thromb Res"},{"key":"10.1053\/j.seminhematol.2004.10.002_bib39","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1055\/s-0037-1613759","article-title":"The half-life of infused factor VIII is shorter in hemophiliac patients with blood group O than in those with blood group A","volume":"83","author":"Vlot","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1053\/j.seminhematol.2004.10.002_bib40","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1182\/blood.V63.6.1369.1369","article-title":"A new variant of dominant type II von Willebrand\u2019s disease with aberrant multimeric pattern of factor VIII-related antigen (type IID)","volume":"63","author":"Kinoshita","year":"1984","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2004.10.002_bib41","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1172\/JCI110700","article-title":"Aberrant multimeric structure of von Willebrand factor in a new variant of von Willebrand\u2019s disease (type IIC)","volume":"70","author":"Ruggeri","year":"1982","journal-title":"J Clin Invest"},{"key":"10.1053\/j.seminhematol.2004.10.002_bib42","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1182\/blood.V82.1.169.bloodjournal821169","article-title":"New variant of von Willebrand disease type II with markedly increased levels of von Willebrand factor antigen and dominant mode of inheritance","volume":"82","author":"Ledford","year":"1993","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2004.10.002_bib43","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1172\/JCI112394","article-title":"Subunit composition of plasma von Willebrand factor. Cleavage is present in normal individuals, increased in IIA and IIB von Willebrand disease, but minimal in variants with aberrant structure of individual oligomers (types IIC, IID and IIE)","volume":"77","author":"Zimmerman","year":"1986","journal-title":"J Clin Invest"},{"key":"10.1053\/j.seminhematol.2004.10.002_bib44","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1182\/blood.V68.1.149.149","article-title":"A new von Willebrand variant (type I, New York)","volume":"68","author":"Weiss","year":"1986","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2004.10.002_bib45","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1182\/blood.V68.3.668.668","article-title":"von Willebrand\u2019s disease characterized by increased ristocetin sensitivity and the presence of all von Willebrand factor multimers in plasma","volume":"68","author":"Holmberg","year":"1986","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2004.10.002_bib46","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0049-3848(97)00104-7","article-title":"New families with von Willebrand disease type 2M (Vicenza)","volume":"87","author":"Zieger","year":"1987","journal-title":"Thromb Res"},{"key":"10.1053\/j.seminhematol.2004.10.002_bib47","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1055\/s-0038-1648458","article-title":"Von Willebrand disease masquerading as haemophilia A","volume":"67","author":"Mazurier","year":"1992","journal-title":"Thromb Haemost"},{"key":"10.1053\/j.seminhematol.2004.10.002_bib48","doi-asserted-by":"crossref","first-page":"4463","DOI":"10.1182\/blood.V92.12.4663","article-title":"A novel mutation in the D3 domain of von Willebrand factor markedly decreases its ability to bind factor VIII and affects its multimerization","volume":"92","author":"Jorieux","year":"1998","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2004.10.002_bib49","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.1182\/blood.V95.10.3139","article-title":"Conformational changes in the D\u2032 domain of von Willebrand factor induced by CYS25 and CYS95 mutations lead to factor VIII binding defect and multimeric impairment","volume":"95","author":"Jorieux","year":"2000","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2004.10.002_bib50","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1182\/blood.V95.6.2000","article-title":"Two novel type 2N von Willebrand disease-causing mutations that result in defective factor VIII binding, multimerization, and secretion of von Willebrand factor","volume":"95","author":"Allen","year":"2000","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2004.10.002_bib51","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1093\/hmg\/1.9.767","article-title":"A single cytosine deletion in exon 18 of the von Willebrand factor gene is the most common mutation in Swedish vWD type III patients","volume":"1","author":"Zhang","year":"1992","journal-title":"Hum Mol Genet"},{"key":"10.1053\/j.seminhematol.2004.10.002_bib52","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1007\/BF00206958","article-title":"Genetic heterogeneity of severe von Willebrand disease type III in the German population","volume":"94","author":"Schneppenheim","year":"1994","journal-title":"Hum Genet"},{"key":"10.1053\/j.seminhematol.2004.10.002_bib53","first-page":"3132","article-title":"Delta C in exon 18 of the von Willebrand factor gene is the most common mutation in patients with severe von Willebrand disease type 3 in Poland","volume":"90","author":"Gazda","year":"1997","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2004.10.002_bib54","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1172\/JCI109795","article-title":"Variant von Willebrand\u2019s disease","volume":"65","author":"Ruggeri","year":"1980","journal-title":"J Clin Invest"},{"key":"10.1053\/j.seminhematol.2004.10.002_bib55","doi-asserted-by":"crossref","first-page":"6306","DOI":"10.1073\/pnas.87.16.6306","article-title":"Identification of a cleavage site directing the immunochemical detection of molecular abnormalities in type IIA von Willebrand factor","volume":"87","author":"Dent","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.seminhematol.2004.10.002_bib56","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1172\/JCI115122","article-title":"Molecular basis of von Willebrand disease type IIB. Candidate mutations cluster in one disulfide loop between proposed platelet glycoprotein Ib binding sequences","volume":"87","author":"Randi","year":"1991","journal-title":"J Clin Invest"},{"key":"10.1053\/j.seminhematol.2004.10.002_bib57","doi-asserted-by":"crossref","first-page":"4223","DOI":"10.1182\/blood.V87.10.4223.bloodjournal87104223","article-title":"Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis","volume":"87","author":"Furlan","year":"1996","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2004.10.002_bib58","doi-asserted-by":"crossref","first-page":"4235","DOI":"10.1182\/blood.V87.10.4235.bloodjournal87104235","article-title":"Physiologic cleavage of von Willebrand factor by a plasma protease is dependent on its conformation and requires calcium ion","volume":"87","author":"Tsai","year":"1996","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2004.10.002_bib59","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1182\/blood.V98.3.674","article-title":"Aberrant dimerization of von Willebrand factor as the result of mutations in the carboxy-terminal region","volume":"98","author":"Enayat","year":"2001","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2004.10.002_bib60","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1055\/s-0038-1649724","article-title":"Requirement for both D domains of the propolypeptide in von Willebrand factor multimerization and storage","volume":"70","author":"Journet","year":"1993","journal-title":"Thromb Haemost"},{"key":"10.1053\/j.seminhematol.2004.10.002_bib61","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1182\/blood.V88.7.2433.bloodjournal8872433","article-title":"Dominant type 1 von Willebrand disease caused by mutated cysteine residues in the D3 domain of von Willebrand factor","volume":"88","author":"Eikenboom","year":"1996","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2004.10.002_bib62","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1055\/s-0037-1613232","article-title":"Von Willebrand\u2019s disease caused by compound heterozygosity for a substitution mutation (T1156M) in the D3 domain of the von Willebrand factor and a stop mutation (Q2470X)","volume":"88","author":"Lethagen","year":"2002","journal-title":"Thromb Haemost"},{"key":"10.1053\/j.seminhematol.2004.10.002_bib63","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S1079-9796(03)00033-0","article-title":"Molecular defects in type 3 von Willebrand disease","volume":"30","author":"Baronciani","year":"2003","journal-title":"Blood Cells Mol Dis"},{"key":"10.1053\/j.seminhematol.2004.10.002_bib64","doi-asserted-by":"crossref","first-page":"6753","DOI":"10.1016\/S0021-9258(17)37439-2","article-title":"Disulfide bonds required to assemble functional von Willebrand factor multimers","volume":"269","author":"Dong","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1053\/j.seminhematol.2004.10.002_bib65","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1172\/JCI116443","article-title":"von Willebrand factor mutation enhancing interaction with platelets in patients with normal multimeric structure","volume":"91","author":"Holmberg","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1053\/j.seminhematol.2004.10.002_bib66","doi-asserted-by":"crossref","first-page":"15035","DOI":"10.1074\/jbc.M208977200","article-title":"Mapping the collagen-binding site in the von Willebrand factor-A3 domain","volume":"278","author":"Romijn","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1053\/j.seminhematol.2004.10.002_bib67","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1055\/s-0037-1613060","article-title":"Identification of a new type 2M von Willebrand disease mutation also at position 1324 of von Willebrand factor","volume":"87","author":"Hilbert","year":"2002","journal-title":"Thromb Haemost"},{"key":"10.1053\/j.seminhematol.2004.10.002_bib68","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1067\/mlc.2001.111252","article-title":"Type 2M von Willebrand disease variant characterized by abnormal von willebrand factor multimerization","volume":"137","author":"Casonato","year":"2001","journal-title":"J Lab Clin Med"},{"key":"10.1053\/j.seminhematol.2004.10.002_bib69","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1182\/blood.V91.5.1572","article-title":"Type 2M von Willebrand disease","volume":"91","author":"Hillery","year":"1998","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2004.10.002_bib70","first-page":"707","article-title":"Quatre cas de deficit acquis en facteur Willebrand associ\u00e9s a une dysgubulin\u00e9mie monoclonale","volume":"143","author":"Horellou","year":"1983","journal-title":"Ann Med Intern"},{"key":"10.1053\/j.seminhematol.2004.10.002_bib71","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1056\/NEJMra020528","article-title":"Thrombotic microangiopathies","volume":"347","author":"Moake","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminhematol.2004.10.002_bib72","doi-asserted-by":"crossref","first-page":"10578","DOI":"10.1073\/pnas.0402041101","article-title":"Binding of platelet glycoprotein Ib (\u03b1) to von Willebrand factor domain A1 stimulates the cleavage of the adjacent domain A2 by ADAMTS13","volume":"101","author":"Nishio","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.seminhematol.2004.10.002_bib73","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1055\/s-0037-1614162","article-title":"Identifications of type 2 von Willebrand disease in previously diagnosed type 1 patients","volume":"84","author":"Nitu-Whalley","year":"2000","journal-title":"Thromb Haemost"}],"container-title":["Seminars in Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196304002501?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196304002501?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T06:15:08Z","timestamp":1758521708000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0037196304002501"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1]]},"references-count":73,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,1]]}},"alternative-id":["S0037196304002501"],"URL":"https:\/\/doi.org\/10.1053\/j.seminhematol.2004.10.002","relation":{},"ISSN":["0037-1963"],"issn-type":[{"value":"0037-1963","type":"print"}],"subject":[],"published":{"date-parts":[[2005,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phenotypic and genotypic diagnosis of von Willebrand disease: A 2004 update","name":"articletitle","label":"Article Title"},{"value":"Seminars in Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.seminhematol.2004.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}